Combination antibiotic therapy for invasive infections with Gram-negative bacteria is
employed in many health care facilities, especially for certain subgroups of patients …

More than a decade ago ciprofloxacin, the first quinolone with broad indications, was
released for clinical use in the United States. The release of ofloxacin, which also had broad …

Infectious diseases are important causes of morbidity and mortality in patients with cancer.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and …

This document updates and expands the initial Infectious Diseases Society of America
(IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in …

Purpose To provide guidelines on antimicrobial prophylaxis for adult neutropenic oncology
outpatients and on selection and treatment as outpatients of those with fever and …

This article, prepared by the Infectious Diseases Society of America (IDSA) Fever and
Neutropenia Guidelines Panel, updates guidelines established a decade ago by the …

Patients with cancer are at increased risk for developing infectious complications during the
course of their disease and treatment. The following sections of the NCCN Clinical Practice …

Purpose To validate a prognostic score predicting major complications in patients with solid
tumors and seemingly stable episodes of febrile neutropenia (FN). The definition of clinical …

Background Intravenously administered antimicrobial agents have been the standard choice
for the empirical management of fever in patients with cancer and granulocytopenia. If orally …

Cytostatic chemotherapy of hematological malignancies is often complicated by
neutropenia, which increases the risk of infections, especially if the neutrophil count is below …